Animal models for highly pathogenic emerging viruses

Current Opinion in Virology

Volumn 3, Issue 2, 2013, Pages 205-209

  Safronetz, David ^a   Geisbert, Thomas W ^b   Feldmann, Heinz ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

APOPTOSIS; ARBOVIRUS; ARENAVIRUS; ARTICLE; BLOOD CLOTTING DISORDER; BUNYAVIRUS; CYTOKINE PRODUCTION; DISEASE MODEL; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; FILOVIRUS; GOLD STANDARD; HENDRA VIRUS; IMMUNOGENICITY; NIPAH VIRUS; NONHUMAN; PARAMYXOVIRUS; PATHOGENESIS; PRIMATE; PRIORITY JOURNAL; VIRAL TROPISM; VIREMIA; VIRUS REPLICATION; VIRUS VIRULENCE;

EID: 84880074577     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2013.01.001     Document Type: Review

References (12)

1. Paweska JT, Sewlall NH, Ksiazek TG, Blumberg LH, Hale MJ, Lipkin WI, Weyer J, Nichol ST, Rollin PE, McMullan LK et al.: Nosocomial outbreak of novel arenavirus infection, southern Africa. Emerg Infect Dis 2009, 15:1598-1602.
2. Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, Zhang L, Zhang QF, Popov VL, Li C et al.: Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med 2011, 364:1523-1532.
3. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012, 367: 1814-1820.
4. FDA: Guidance for Industry: Animal Model-Essential Elements to Address Efficacy Under the Animal Rule. 2009 http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm078923.pdf.
5. Bradfute SB, Warfield KL, Bray M: Mouse models for filovirus infections. Viruses 2012, 4:1477-14508.
6. Bird BH, Dodd KA, Erickson BR, Albariño CG, Chakrabarti AK, McMullan LK, Bergeron E, Ströeher U, Cannon D, Martin B: Severe hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virus. PLoS Negl Trop Dis 2012:e1801.
7. Safronetz D, Ebihara H, Feldmann H, Hooper JW: The Syrian hamster model of hantavirus pulmonary syndrome. Antiviral Res 2012, 95:282-292.
8. Rockx B, Winegar R, Freiberg AN: Recent progress in henipavirus research: molecular biology, genetic diversity, animal models. Antiviral Res 2012, 95:135-149.
9. Rockx B, Brining D, Kramer J, Callison J, Ebihara H, Mansfield K, Feldmann H: Clinical outcome of henipavirus infection in hamsters is determined by the routes and dose of infection. J Virol 2011, 85:7658-7671.
10. Ebihara H, Zivcec M, Gardner D, Falzarano D, Lacasse R, Rosenke R, Long D, Haddock E, Fischer E, Kawaoka Y, Feldmann H: A Syrian golden hamster model recapitulating ebola hemorrhagic Fever. J Infect Dis 2013, 207:306-318.
11. Wahl-Jensen V, Bollinger L, Safronetz D, de Kok-Mercado F, Scott DP, Ebihara H: Use of the Syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers. Viruses 2012, 4:3754-3784.
12. Saldarriaga OA, Travi BL, Choudhury GG, Melby PC: Identification of hamster inducible nitric oxide synthase (iNOS) promoter sequences that influence basal and inducible iNOS expression. J Leukoc Biol 2012, 92:205-218.